ClinVar Miner

Submissions for variant NM_001142446.2(ANK1):c.127-39554G>A

gnomAD frequency: 0.01664  dbSNP: rs183894680
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
CeGaT Center for Human Genetics Tuebingen RCV003430625 SCV004157528 benign not provided 2024-06-01 criteria provided, single submitter clinical testing ANK1: BS1, BS2
Mayo Clinic Laboratories, Mayo Clinic RCV003430625 SCV004228205 uncertain significance not provided 2023-05-19 criteria provided, single submitter clinical testing BS1, BS2, BP4, BP7
OMIM RCV000000541 SCV000020690 pathogenic Spherocytosis, type 1, autosomal recessive 2000-12-01 no assertion criteria provided literature only
Reproductive Health Research and Development, BGI Genomics RCV000000541 SCV001142390 benign Spherocytosis, type 1, autosomal recessive 2020-01-06 no assertion criteria provided curation NG_012820.1(NM_001142446.2):c.127-39554G>A in the ANK1 gene has an allele frequency of 0.02 in African subpopulation in the gnomAD database. 6 homozygous occurrences are observed in the gnomAD database. This variant was reported as -153G-A in a hereditary spherocytosis patient (PMID: 11102985). Benign computational verdict because benign prediction from DANN. Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS1, BS2, BP4.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.